Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
Loraine Kay D. Cabral, Claudio Tiribelli, Caecilia Sukowati
Cancers (2020) Vol. 12, Iss. 6, pp. 1576-1576
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Mechanisms of drug resistance in HCC
Alexandra D. Ladd, Sergio Duarte, İlyas Şahin, et al.
Hepatology (2023)
Closed Access | Times Cited: 144
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
Yuanjun Lu, Yau-Tuen Chan, Hor‐Yue Tan, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 142
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 29
RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis
Ha Zhu, Kun Chen, Yali Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma
Fenglin Dong, Zongzhen Xu, Ying-Qiao Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials
Lisha Mou, Xiaohe Tian, Bo Zhou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 52
USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes
Hiroshi Kitamura, Mayuko Hashimoto
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1209-1209
Open Access | Times Cited: 49
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
Francesca Fornari, Catia Giovannini, Fabio Piscaglia, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 741-757
Open Access | Times Cited: 49
Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
Danyang Li, Yingcheng Yao, Yuhan Rao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 34
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway
Qing Tang, Xiaojuan Li, Yun Chen, et al.
Molecular Carcinogenesis (2022) Vol. 61, Iss. 4, pp. 417-432
Open Access | Times Cited: 32
Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma
Yuxue Gao, Qingguo Xu, Xinqiang Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 31
Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy
Linzhuo Huang, Rui Xu, Weirong Li, et al.
Acta Biomaterialia (2023) Vol. 162, pp. 98-109
Closed Access | Times Cited: 18
SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction
Yue Guo, Haitao Hu, Wenbo Chen, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 7
Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
Lai Wei, Zeyu Wang, Niancai Jing, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 24
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling
Hanif Khan, Zhengzhong Ni, Hai Feng, et al.
Phytomedicine (2021) Vol. 91, pp. 153706-153706
Open Access | Times Cited: 29
Single-Cell RNA Sequencing Reveals the Role of Phosphorylation-Related Genes in Hepatocellular Carcinoma Stem Cells
Fuwen Yao, Yongqiang Zhan, Changzheng Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 21
mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A
Liang Zhao, Huizhao Su, Xiaomeng Liu, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Targeting ferroptosis in hepatocellular carcinoma
Yuqian Mo, Zhilin Zou, Erbao Chen
Hepatology International (2023) Vol. 18, Iss. 1, pp. 32-49
Closed Access | Times Cited: 12
CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway
Zhengchen Jiang, Bowen Shi, Yun Zhang, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108843-108843
Open Access | Times Cited: 4
The knowledge mapping of traditional Chinese medicine for hepatocellular carcinoma: A bibliometric study
Wenya Pei, Boyu Jiao, Zexiong Chen, et al.
Pharmacological Research - Modern Chinese Medicine (2025) Vol. 14, pp. 100581-100581
Open Access
Pharmacogenomic insights: IL-23R and ATG-10 polymorphisms in Sorafenib response for hepatocellular carcinoma
Asmaa Elsheshtawy, Rehab H. Werida, Monir Bahgat, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Induction of UBQLN1‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells
Xuefen Xu, Weidong Li, Ya Zhou, et al.
BioFactors (2025) Vol. 51, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top